Navigation Links
Ahram Biosystems Completes Development of a Palm-Size Portable PCR Device
Date:6/17/2008

New instrument system delivers highly efficient and fast PCR amplification

in a fully portable format

SAN DIEGO, June 17 /PRNewswire/ -- Ahram Biosystems, Inc., a leading developer of state-of-the-art PCR devices and Cell-based assay systems, today announced at the BIO 2008 Annual International Convention at the San Diego Convention Center that it has successfully completed development of Palm PCR, a palm-size portable thermocycler capable of delivering PCR amplified product in as little as 15 minutes. This device features the smallest size of all the PCR devices on the market.

"We are very excited to introduce our novel and truly hand-held portable PCR device as it provides not only the fastest amplification but is highly efficient with a wide dynamic range, yet adapting the standard 9 mm-spaced well format with a disposable plastic tube," said Dr. Hyun Jin Hwang, Ahram's Chairman and CEO.

"The ability to achieve rapid PCR amplification in a fully portable format will not only enable researchers to perform conventional laboratory experiments more effectively, but will also significantly ease other downstream applications such as those requiring in-situ or on-site genomic detection," said Dr. Jane Kim, Ahram's CSO.

Palm PCR is a battery-powered stand-alone portable thermocycler designed for simplicity and robustness. In spite of its very small size, this powerful device delivers highly efficient and fast amplification for nearly all kinds of DNA samples including the human genome. Even a single copy of DNA can be amplified in as little as 25 minutes to an amount sufficient for typical agarose-gel detection. The system provides both new and experienced researchers with a highly-functional and easy-to-use way to conduct various PCR experiments. "It has the lowest power consumption of all the commercially available thermocyclers (< 5 watts) to date, is capable of achieving uniformity better than +/- 0.1 degrees C and can run for more than 4 hours on a single charge of a Li-ion battery," added Dr. Hwang.

Ahram Biosystems is located at booth # 4142 in the BIO exhibition hall.

About Ahram Biosystems:

Ahram Biosystems, Inc. is a privately held biotechnology company based in Seoul, Korea that develops and commercializes innovative portable high-speed PCR devices and Cell-based assay systems. Founded in 2001, the company globally employs approximately 20 professionals in South Korea and USA. For more information, visit http://www.ahrambio.com.


'/>"/>
SOURCE Ahram Biosystems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
2. Open Biosystems Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland
3. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
4. Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina
5. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
6. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
7. Primera Biosystems Raises $21 Million in Series B Private Round
8. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
9. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
10. China Sun Group High-Tech Co. Completes Share Exchange to Create 100% Ownership in DLX Subsidiary
11. EnzySurge, Maker of DermaStream(TM), Completes Funding Round of US$4 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company ... for the treatment of prostate, brain, lung, head and ... for the second quarter and six months of fiscal ... --> --> Revenue was $1.19 ... ended December 31, 2015, a 12% increase compared to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Benchmark Research, a ... promotion of two long-standing principal investigators (PI) to the roles of Chief Medical ... Development. , Dr. Laurence Chu, a Benchmark Research PI in the Austin office, ...
(Date:2/10/2016)... ... February 10, 2016 , ... SonaCare Medical, LLC reports the ... Sonalinkā„¢ remote monitoring. The inaugural launch of this new technology occurred over the ... Samuel Peretsman to a HIFU technical expert at SonaCare Medical headquarters. , ...
(Date:2/10/2016)... ... 10, 2016 , ... Global Stem Cells Group, ... Global Stem Cells Network (GSCN) and its affiliate Global Medical Training Network ... adipose and bone marrow therapies. , Through the new collaboration, Global Stem ...
Breaking Biology Technology:
(Date:1/28/2016)... SYNA ), a leading developer of human interface solutions, today ... --> --> Net revenue ... to the comparable quarter last year to $470.5 million. Net income ... $0.93 per diluted share. --> ... 2016 grew 9 percent over the prior year period to $60.3 ...
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the ... pharma and publication industries, will provide the data management ... Centre (NPSC). ... Phenotypic analysis measures ... whole organisms, allowing comparisons between states such as health ...
(Date:1/21/2016)... , January 21, 2016 ... to a new market research report "Emotion Detection and ... Others), Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020", published by MarketsandMarkets, ... expected to reach USD 22.65 Billion by 2020, ...
Breaking Biology News(10 mins):